Management of central venous catheters in patients with cancer and candidemia

被引:120
作者
Raad, I
Hanna, H
Boktour, M
Girgawy, E
Danawi, H
Mardani, M
Kontoyiannis, D
Darouiche, R
Hachem, R
Bodey, GP
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Univ Texas, Sch Publ Hlth, Houston, TX USA
关键词
D O I
10.1086/382874
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the need and appropriate timing of catheter removal in patients with candidemia, the records for 404 patients with cancer and central venous catheters (CVCs) who developed candidemia during the period of 1993 - 1998 were retrospectively reviewed. Of the total 404 cases of candidemia, 241 (60%) were due to a primary source, 111 (27%) were catheter related, and 52 (13%) were secondary cases of candidemia caused by a source other than the catheter. Multivariate analysis showed that catheter removal less than or equal to 72 h after onset improved response to antifungal therapy exclusively in patients with catheter-related candidemia (P = .04). Pp. 04 Clinical characteristics that suggested a noncatheter source for the candidemia were disseminated infection (P < .01), previous chemotherapy (P < .01), previous corticosteroid therapy (P = .02), and poor response to antifungal therapy (P < .03). CVC removal <= 72 h after onset should be considered in patients with suspected catheter-related candidemia who have no evidence of dissemination, recent corticosteroid therapy, or chemotherapy.
引用
收藏
页码:1119 / 1127
页数:9
相关论文
共 39 条
  • [1] Candida krusei fungemia -: An escalating serious infection in immunocompromised patients
    Abbas, J
    Bodey, GP
    Hanna, HA
    Mardani, M
    Girgawy, E
    Abi-Said, D
    Whimbey, E
    Hachem, R
    Raad, I
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) : 2659 - 2664
  • [2] Predictors of adverse outcome in cancer patients with candidemia
    Anaissie, EJ
    Rex, JH
    Uzun, Ö
    Vartivarian, S
    [J]. AMERICAN JOURNAL OF MEDICINE, 1998, 104 (03) : 238 - 245
  • [3] BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
  • [4] The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer
    Bodey, GP
    Mardani, M
    Hanna, HA
    Boktour, M
    Abbas, J
    Girgawy, E
    Hachem, RY
    Kontoyiannis, DP
    Raad, II
    [J]. AMERICAN JOURNAL OF MEDICINE, 2002, 112 (05) : 380 - 385
  • [5] BODEY GP, 1993, CANDIDIASIS PATHOGEN, P407
  • [6] CANDIDEMIA IN CHILDREN WITH CENTRAL VENOUS CATHETERS - ROLE OF CATHETER REMOVAL AND AMPHOTERICIN-B THERAPY
    DATO, VM
    DAJANI, AS
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (05) : 309 - 314
  • [7] EPPES SC, 1989, PEDIATR INFECT DIS J, V8, P99
  • [8] Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: Clinical aspects, predisposing factors, and differential pathogenicity of the causative strains
    Girmenia, C
    Martino, P
    DeBernardis, F
    Gentile, G
    Boccanera, M
    Monaco, M
    Antonucci, G
    Cassone, A
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) : 506 - 514
  • [9] Virus: A case-control study
    Gonzalez, CE
    Venzon, D
    Lee, S
    Mueller, BU
    Pizzo, PA
    Walsh, TJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) : 515 - 521
  • [10] CLINICAL-FEATURES AND ANALYSIS OF RISK-FACTORS FOR INVASIVE CANDIDAL INFECTION AFTER MARROW TRANSPLANTATION
    GOODRICH, JM
    REED, EC
    MORI, M
    FISHER, LD
    SKERRETT, S
    DANDLIKER, PS
    KLIS, B
    COUNTS, GW
    MEYERS, JD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (04) : 731 - 740